T26	MRSA	T23	stool swab cultures
T26	MRSA	T21	Nares and stool swab cultures
T26	MRSA	T22	stool
T26	MRSA	T20	Nares
T5	R. eutropha H850	T6	fructose medium
T6	Anabaena sp. strain L-31	T5	soil
T7	Campylobacter jejuni	T5	human
T7	Campylobacter jejuni	T6	human gastrointestinal
T5	Zobellia galactanivorans Dsij	T4	marine
T5	Xanthomonas campestris pv. vesicatoria	T4	plant
T31	E. coli O157:H7	T33	NB
T31	E. coli O157:H7	T29	TSB
T31	E. coli O157:H7	T32	TSB
T17	Escherichia coli O157:H7	T28	TSB
T17	Escherichia coli O157:H7	T27	apple surfaces
T17	Escherichia coli O157:H7	T23	NB
T17	Escherichia coli O157:H7	T24	lettuce
T17	Escherichia coli O157:H7	T15	nutrient broth
T17	Escherichia coli O157:H7	T26	apple
T17	Escherichia coli O157:H7	T25	lettuce and apple surfaces
T17	Escherichia coli O157:H7	T12	tryptic soy broth
T31	E. coli O157:H7	T30	NB
T13	N. gonorrhoeae	T10	laboratories
T13	N. gonorrhoeae	T12	Caribbean
T13	N. gonorrhoeae	T11	Americas
T5	Escherichia coli O157:H7	T4	food
T6	S. marcescens MG1	T8	biofilm
T8	Staphylococcus epidermidis	T7	Biomaterial
T9	Staphylococcus aureus	T7	Biomaterial
T16	Enterococcus	T8	sputum of patients who accepted chemotherapy
T14	Acinetobacter baumannii	T7	urine and sputum of patients who accepted chemotherapy
T16	Enterococcus	T10	nosocomial
T16	Enterococcus	T7	urine and sputum of patients who accepted chemotherapy
T16	Enterococcus	T9	patients who accepted chemotherapy
T16	Enterococcus	T6	blood, urine and sputum of patients who accepted chemotherapy
T11	Pseudomonas aeruginosa	T9	patients who accepted chemotherapy
T11	Pseudomonas aeruginosa	T6	blood, urine and sputum of patients who accepted chemotherapy
T11	Pseudomonas aeruginosa	T10	nosocomial
T11	Pseudomonas aeruginosa	T7	urine and sputum of patients who accepted chemotherapy
T11	Pseudomonas aeruginosa	T8	sputum of patients who accepted chemotherapy
T12	Enterobacter cloacae	T7	urine and sputum of patients who accepted chemotherapy
T12	Enterobacter cloacae	T9	patients who accepted chemotherapy
T12	Enterobacter cloacae	T10	nosocomial
T12	Enterobacter cloacae	T8	sputum of patients who accepted chemotherapy
T12	Enterobacter cloacae	T6	blood, urine and sputum of patients who accepted chemotherapy
T13	E. coli	T8	sputum of patients who accepted chemotherapy
T13	E. coli	T7	urine and sputum of patients who accepted chemotherapy
T13	E. coli	T6	blood, urine and sputum of patients who accepted chemotherapy
T13	E. coli	T10	nosocomial
T14	Acinetobacter baumannii	T8	sputum of patients who accepted chemotherapy
T13	E. coli	T9	patients who accepted chemotherapy
T14	Acinetobacter baumannii	T6	blood, urine and sputum of patients who accepted chemotherapy
T14	Acinetobacter baumannii	T9	patients who accepted chemotherapy
T14	Acinetobacter baumannii	T10	nosocomial
T10	Virchow	T9	Spanish hospitals
T10	Virchow	T8	Spanish
T11	Livingstone	T9	Spanish hospitals
T11	Livingstone	T8	Spanish
T28	M. pneumoniae	T23	CSF
T22	H. influenzae	T29	patients with antibiotic administration
T24	S. pneumoniae	T23	CSF
T24	S. pneumoniae	T29	patients with antibiotic administration
T25	S. agalactiae	T29	patients with antibiotic administration
T25	S. agalactiae	T23	CSF
T26	E. coli	T23	CSF
T26	E. coli	T29	patients with antibiotic administration
T27	L. monocytogenes	T23	CSF
T27	L. monocytogenes	T29	patients with antibiotic administration
T28	M. pneumoniae	T29	patients with antibiotic administration
T20	TFM	T18	live vaccine
T27	TFM	T26	Japanese flounder
T14	S. aureus	T11	primary and secondary mannitol salts
T14	S. aureus	T7	jail
T14	S. aureus	T12	oxacillin-resistant screening agar
T14	S. aureus	T8	jail environmental surfaces
T15	MRSA	T12	oxacillin-resistant screening agar
T15	MRSA	T16	inmates' nasal
T15	MRSA	T11	primary and secondary mannitol salts
T15	MRSA	T7	jail
T15	MRSA	T17	inmates
T15	MRSA	T8	jail environmental surfaces
T20	MRSA	T19	correctional facilities
T16	Mycobacterium leprae	T15	human
T25	M. leprae	T24	myelin-free cells
T19	F. tularensis	T18	J774 cells
T22	F. tularensis	T21	J774 cell line
T6	Staphylococcus aureus	T5	human
T36	C. perfringens	T35	intestinal
T7	Clostridium difficile	T16	Olmsted County
T7	Clostridium difficile	T9	inpatient cases of CDI (48.6% female; median age, 62.5 years; range, 0.1-103.7 years)
T7	Clostridium difficile	T11	Patients with severe-complicated CDI
T7	Clostridium difficile	T22	patients
T7	Clostridium difficile	T23	Olmsted County
T7	Clostridium difficile	T17	Minnesota
T7	Clostridium difficile	T13	hospitalized patients
T7	Clostridium difficile	T15	inpatients
T7	Clostridium difficile	T29	hospitalized patients
T7	Clostridium difficile	T19	inpatients
T9	Campylobacter	T8	clinical
T13	Campylobacter	T12	UK
T17	Campylobacter	T16	chicken
T10	Salmonella Paratyphi A	T9	Asia
T12	S. Paratyphi A	T14	Nepal
T12	S. Paratyphi A	T13	Israeli travelers
T18	S. Paratyphi A	T16	Israeli travelers
T18	S. Paratyphi A	T17	Nepal
T18	S. Typhimurium	T16	intracloacal
T18	S. Typhimurium	T17	chickens
T20	Salmonella	T17	chickens
T22	Salmonella	T26	chicks
T22	Salmonella	T25	caecal wall of the chicks
T11	MRSA	T14	patient
T13	VRE	T14	patient
T18	Mtb	T17	Mtb-infected human blood
T4	Pseudomonas aeruginosa	T7	patients with CF
T4	Pseudomonas aeruginosa	T6	clinical
T4	Vibrio salmonicida	T3	fish
T9	Vibrio salmonicida	T8	fish
T19	V. salmonicida	T22	sediment sample from a disease-free fish farm
T19	V. salmonicida	T23	disease-free fish farm
T15	C. burnetii	T13	infected yolk sacs
T3	Coxiella burnetii	T11	infected yolk sacs
T6	Mycobacterium tuberculosis	T3	Macaca mulatta sensitized with bacille Calmette Guerin cell wall vaccine and-or infected with virulent Mycobacterium tuberculosis
T15	Mycoplasma pneumoniae	T13	patients with WARI
T2	Serratia	T5	Italy
T2	Serratia	T3	Hospital S. Camillo De Lellis
T2	Serratia	T4	Roma
T13	V. cholerae O:1	T12	people with V. cholerae O:1 infection
T19	V. cholerae O:1	T25	Arselle
T18	serotypes A	T16	cases of trachoma
T17	serotypes A, B	T16	cases of trachoma
T19	serotypes A, B and C	T16	cases of trachoma
T21	serotypes D-I	T20	oculogenital origin
T29	H. pylori	T28	patients
T4	Kingella kingae	T3	Respiratory
T31	K. kingae	T30	day-care center attendees
T31	K. kingae	T26	throat
T31	K. kingae	T25	throat cultures
T32	K. kingae	T34	children
T32	K. kingae	T33	children
T36	K. kingae	T38	surgical patients
T36	K. kingae	T35	colonized children
T36	K. kingae	T37	pharyngeal
T13	non-O1 V. cholerae	T11	blood culture
T13	non-O1 V. cholerae	T12	blood
T13	non-O1 V. cholerae	T15	Patients with underlying cirrhosis and the aforementioned bacteremia
T28	non-O1 V. cholerae	T27	Patients with decompensated cirrhosis
T11	mycobacteria	T8	animal models
T11	mycobacteria	T7	man and animal models
T12	mycobacterial	T8	animal models
T12	mycobacterial	T7	man and animal models
T8	H. pullorum	T7	human
T5	Agrobacterium rhizogenes	T7	plant
T3	Mycobacterium kansasii	T2	Gingivomandibular
T8	Escherichia coli	T6	healthy cows
T15	H. pylori	T14	Subjects with hypoacidity
T23	H. pylori	T24	HIV-positive black and Hispanic populations
